… In this trial (NCT04746183) we evaluated the safety and optimal dose of … safety and tolerability
of multiple ascending doses of molnupiravir in participants with PCR-confirmed SARS-CoV…

… is novel in its inclusion of dose-safety and dose-cost models and … to hypothesize the best
dosing for a candidate SARS-CoV-2 … Finally, the dose-seroconversion and dose-safety models …

… safety of a SARS-CoV-2 inactivated vaccine (CoronaVac). … to evaluate the optimal dose,
immunogenicity and safety of the … 2 injections of the trial vaccine at a dose of 3 μg/0.5 mL or 6 μg …

… being developed against SARS-CoV-2. We present interim safety and immunogenicity results
of the … candidate vaccine will focus on identifying the optimal antigen formulation and dose. …

… i Define the optimal drug dose(s) and frequency to achieve unbound concentrations in plasma
and tissue to maximise antiviral and/or disease suppressing activity. For antivirals, this will …

… When used in the treatment of acute worsening of chronic pancreatitis or postoperative
reflux oesophagitis, the recommended dosage is 300-600 mg/day in three dosages of 100-200 …

… Due to the impossibility of not using the drug recommended at the national … dosage of CQ
(12 g total dose over 10 days) in COVID-19 should not be recommended because of safety …

… of immune protection from symptomatic SARS-CoV-2 infection … ) received both doses of the
vaccine at the recommended 1-… the first dose and so did not receive a second dose. Baseline …

… in similar studies demonstrating the safety of a 2-dose schedule. Second, we … recommended
the 3-dose schedule. Most of the participants had already received 2 doses of SARS-CoV-2 …

… of mRNA and/or ChAdOx1 vaccines gave excellent protection against … doses improved VE
and may be optimal in most circumstances. Findings indicate prolonged two-dose protection …